Neoplasms

All Conditions

Digestive System Diseases

Carcinoma

Rectal Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Intestinal Diseases

Rectal Diseases

Colonic Diseases

Micronutrients

All Drugs and Chemicals

Antineoplastic Agents

Hematinics

Vitamins

Leucovorin

Fluorouracil

Antimetabolites

Immunosuppressive Agents

Immunologic Factors

Antidotes

Protective Agents

Folic Acid

Vitamin B Complex

Trace Elements

Folate

Vitamin B9

CoFactor

5-FU

James Cassidy, MD

The objective of this trial is to compare efficacy and safety of CoFactor and 5-fluorouracil (5-FU) versus leucovorin and 5-FU in treatment of metastatic colorectal cancer.

Clinical Trial in Patients With Metastatic Colorectal Cancer

A Multi-Center, Open Label, Parallel Group, Randomised, Phase IIB Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-FU Versus Leucovorin and 5-FU in Subjects With Metastatic Colorectal Carcinoma

Mast Therapeutics, Inc.

Joachim Schupp, MD

Bevacizumab

Antineoplastic Agents, Immunological

Angiogenesis Inhibitors

Growth Inhibitors

5- Fluorouracil (5-FU)

bevacizumab (Avastin)

CoFactor (ANX-510)

M. Wasif Saif, MD, MBBS

To compare the progression-free survival time (PFS) in patients treated with 5-FU modulated with CoFactor (plus bevacizumab) to 5-FU modulated with leucovorin (plus bevacizumab) in patients with Metastatic Colorectal Cancer.

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

A Phase III Multi-Center Randomized Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-Fluorouracil (5-FU) Plus Bevacizumab Versus Leucovorin and 5-FU Plus Bevacizumab as Initial Treatment for Metastatic Colorectal Carcinoma

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Clinical Trial in Patients With Metastatic Colorectal Cancer	NCT00235898	Colon Cancer Rectal Cancer	CoFactor 5-FU Leucovorin	18 Years -	Mast Therapeutics, Inc.
Clinical Trial in Patients With Metastatic Colorectal Cancer	NCT00235898	Colon Cancer Rectal Cancer	CoFactor 5-FU Leucovorin	18 Years -	Mast Therapeutics, Inc.
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.	NCT00337389	Metastatic Colo... Colon Cancer Rectal Cancer	5- Fluorouracil... bevacizumab (Av... Leucovorin CoFactor (ANX-5...	18 Years -	Mast Therapeutics, Inc.
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.	NCT00337389	Metastatic Colo... Colon Cancer Rectal Cancer	5- Fluorouracil... bevacizumab (Av... Leucovorin CoFactor (ANX-5...	18 Years -	Mast Therapeutics, Inc.

Spots Global Cancer Trial Database for cofactor

Every month we try and update this database with for cofactor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for cofactor

Every month we try and update this database with for cofactor cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for cofactor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.